New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Unilife Corp (NASDAQ:UNIS), EnteroMedics Inc (NASDAQ: ETRM), Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL), GTx, Inc (NASDAQ:GTXI)
Unilife Corp (NASDAQ:UNIS) the stock opened the session at $4.14 but then moved to $4.05. At that price, the stock showed a negative performance of -1.70%. Unilife Corporation (Unilife) is a developer and commercial supplier injectable drug delivery systems. The Company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its differentiated devices to enable or enhance the clinical development, regulatory approval and lifecycle management of their injectable therapies.
Will UNIS Get Buyers Even After The Recent Rally? Find Out Here
EnteroMedics Inc (NASDAQ: ETRM) opened the session at 2.02and closed the session at $2.04. The stock showed a positive performance of 2.00% in previous trading session. EnteroMedics Inc. (EnteroMedics) is a development- stage medical device company. The Company focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which it refers to as VBLOC therapy, is designed to intermittently block the vagus nerve.
For How Long ETRM will fight for Profitability? Read This Trend Analysis report
Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL) opened the session at $4.48 and closed the session at $4.52. The stock showed a positive performance of 5.61% in previous trading session. Traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 1.38 million shares. The beta of the stock remained 1.95. Gol Linhas Aereas Inteligentes SA (Gol) is a Brazil-based holding company primarily engaged in the passenger air transportation sector. Through its subsidiaries, such as VRG Linhas Aereas SA, GAC Inc and Gol Finance, the Company is involved in the provision of scheduled and non-scheduled passenger air transportation services, as well as cargo and mail bags freight air transportation. The Company offers national and international concessions. Additionally,
Why Should Investors Buy GOL After The Recent Gain? Just Go Here and Find Out
GTx, Inc (NASDAQ:GTXI) the stock decreased -2.23% and finished the session at $1.75. Traded with volume of 1.1 million shares in the prior session and the average volume of the stock remained 539,756.00 shares. The beta of the stock remained 1.39. GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).
Will GTXI Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)